Nucleoside‐Based Drug Target with General Antimicrobial Screening and Specific Computational Studies against SARS‐CoV‐2 Main Protease
SMA Kawsar, MA Hossain, S Saha… - …, 2024 - Wiley Online Library
This review article aims to significantly advance the scientific community's efforts to develop
effective nucleoside‐based drugs for treating severe acute respiratory syndrome …
effective nucleoside‐based drugs for treating severe acute respiratory syndrome …
[HTML][HTML] New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human …
AE Siniavin, VA Gushchin, SS Natal'ya, ES Darnotuk… - Antiviral Research, 2024 - Elsevier
The spread of COVID-19 continues due to genetic variation in SARS-CoV-2. Highly mutated
variants of SARS-CoV-2 have an increased transmissibility and immune evasion. Due to the …
variants of SARS-CoV-2 have an increased transmissibility and immune evasion. Due to the …